.On the heels of an FDA denial for its primary rivalrous Novo Nordisk, Eli Lilly is pushing on in th...
.Just a couple of months after dosing the very first patient in a phase 2 test for freshly diagnosed...
.Eli Lilly's search for obesity targets has led it to the darker genome. The Big Pharma has actually...
.Toolbox Biosciences is actually proceeding up. The tissue therapy business has actually added $325 ...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...
.Aelis Farma's hopes of securing a fast, good decision on a $100 million possibility remittance have...
.ProKidney has actually quit some of a set of phase 3 tests for its own cell treatment for renal ill...
.Vaxcyte revealed what analysts named "spectacular" period 1/2 records for its 31-valent pneumococca...
.Recursion has actually stumbled with a very early test of its tech-enabled strategy to drug explora...
.Call it a situation of good chemical make up: Acepodia, a biotech based on Nobel Champion scientifi...